Pertussis cocoon strategy: Would it be useful for Latin America and other developing countries?

Expert Review of Vaccines

Volumn 11, Issue 12, 2012, Pages 1393-1396

  Ulloa Gutierrez, Rolando ^a   Gentile, Angela ^b   Avila Aguero, Maria L ^a  

^a HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Bordetella pertussis; children; cocoon strategy; developing countries; infants; Latin America; vaccine preventable diseases; vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; EPIDEMIC; GESTATIONAL AGE; HEALTH CARE COST; INCIDENCE; PERTUSSIS; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SOUTH AND CENTRAL AMERICA; VACCINATION;

ANTIBODIES, VIRAL; DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; LATIN AMERICA; PERTUSSIS VACCINE; PREGNANCY; VACCINATION; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 84871550715     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.121     Document Type: Review

References (20)

1. Forsyth KD, Campins-Marti M, Caro J et al.; Global Pertussis Initiative. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin. Infect. Dis. 39(12), 1802-1809 (2004).
2. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25(14), 2634-2642 (2007).
3. American Academy of Pediatrics Commitee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 117(3), 965-978 (2006).
4. Kretsinger K, Broder KR, Cortese MM et al.; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR. Recomm. Rep. 55(RR-17), 1-37 (2006).
5. Centers for Disease Control and Prevention; American Academy of Pediatrics Committee on Infectious Diseases. Additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap). Pediatrics 128(4), 809-812 (2011).
6. Murphy TV, Slade BA, Broder KR et al.; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 57(RR-4), 1-51 (2008).
7. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged 12 months-Advisory Committee on Immunization Practices (ACIP 2011. MMWR Morb. Mortal. Wkly Rep. 60(41), 1424-1426, 2011.
8. Halperin BA, Morris A, Mackinnon-Cameron D et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin. Infect. Dis. 53(9), 885-892 (2011).
9. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheriapertussis vaccine: effect on maternal and neonatal serum antibody levels. Am. J. Obstet. Gynecol. 204(4), 334.e1-334.e5 (2011).
10. Ministerio de Salud de la Nación. Programa Nacional de Control de Enfermedades Inmunoprevenibles Tos convulsa: Alerta epidemiológica, aumento de casos de coqueluche y muertes. 132(32), (2012).
11. Ministerio de Salud de la Nación. Fundamentos de la vacunación de mujeres embarazadas con vacuna triple bacteriana acelular (dTpa). Argentina. 1-23 (2012).
12. Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics 122(3), e550-e555 (2008).
13. Walter EB, Allred N, Rowe-West B, Chmielewski K, Kretsinger K, Dolor RJ. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad. Pediatr. 9(5), 344-347 (2009).
14. Tan TQ, Gerbie MV. Pertussis and patient safety: implementing Tdap vaccine recommendations in hospitals. Jt Comm. J. Qual. Patient Saf. 36(4), 173-178 (2010).
15. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin. Infect. Dis. 52(2), 157-162 (2011).
16. Camenga DR, Kyanko K, Stepczynski J et al. Increasing adult Tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad. Pediatr. 12(1), 20-25 (2012).
17. Lessin HR, Edwards KM; Committee On Practice And Ambulatory Medicine; Committee On Infectious Diseases. Immunizing parents and other close family contacts in the pediatric office setting. Pediatrics 129(1), e247-e253 (2012).
18. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin. Infect. Dis. 54(1), 78-84 (2012).
19. Peters TR, Banks GC, Snively BM, Poehling KA. Potential impact of parental Tdap immunization on infant pertussis hospitalizations. Vaccine 30(37), 5527-5532 (2012).
20. Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin. Infect. Dis. 54(3), 318-327 (2012).